TG68, a Novel Thyroid Hormone Receptor-β Agonist for the Treatment of NAFLD

Activation of thyroid hormone receptor β (THRβ) has shown beneficial effects on metabolic alterations, including non-alcoholic fatty liver disease (NAFLD). Here, we investigated the effect of TG68, a novel THRβ agonist, on fatty liver accumulation and liver injury in mice fed a high-fat diet (HFD)....

Descripción completa

Detalles Bibliográficos
Autores principales: Caddeo, Andrea, Kowalik, Marta Anna, Serra, Marina, Runfola, Massimiliano, Bacci, Andrea, Rapposelli, Simona, Columbano, Amedeo, Perra, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657920/
https://www.ncbi.nlm.nih.gov/pubmed/34884910
http://dx.doi.org/10.3390/ijms222313105

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657920/
https://www.ncbi.nlm.nih.gov/pubmed/34884910
http://dx.doi.org/10.3390/ijms222313105

Ejemplares similares